References
- Goodwin JD. Carcinoid tumors: An analysis of 2 837 cases. Cancer 1975; 36: 560–9
- Moertel C G, Sauer W G, Dockerty M B, Baggentoss AH. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14: 901–12
- Öberg K, Eriksson B. Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncol 1989; 28: 425–31
- Moertel C G, Hanley JA. Combination therapy trials in metastatic carcinoid tumors and the malignant carcinoid syndrome. Cancer Clin Trials 1979; 2: 327–34
- Kvols L K, Moertel C G, O'Connell M S, et al. Treatment of malignant carcinoid syndrome evaluation of a long acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
- Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumors with human leukocyte interferon. Long-term results. Cancer Treat Res 1986; 70: 1297–304
- Grandér D, Öberg K, Lundqvist M-L, et al. Interferon-induced enhancement of 2′-5′-oligoadenylate synthetase in mid-gut carcinoid tumors. Lancet 1990; 336: 337–40
- Norheim I, Öberg K, Theodorsson-Norheim E, et al. Malignant carcinoid tumours: An analysis of 103 patients with regard to tumour localization hormone production and survival. Ann Surg 1987; 206: 115–25